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Abstract 
Abstract 
Background: Inadequate physical activity is a problem for people with Down syndrome and objective 
monitoring using accelerometers may be inaccurate in this population.  
Method: Cross-validation and reliability study comparing two tri-axial accelerometers (the 
SenseWear and RT3) to a criterion measure (the OxyCon Mobile) in 10 young people (mean age: 
20±2) with Down syndrome. A ROC curve analysis was conducted to determine intensity thresholds 
from RT3 activity counts.  
Results: During self-selected pace walking, the accelerometers overestimated energy expenditure 
and had large limits of agreement (SenseWear: -0.5-3.6METs; RT3: -0.2-2.7METs). At this pace 
SenseWear armband step counts were highly correlated with observed steps (r=.98) but 
underestimated steps by up to 12%. We developed RT3 thresholds that demonstrated good to 
excellent sensitivity and specificity in classifying physical activity intensity.    
Conclusions: SenseWear steps and RT3 activity count thresholds can be used to monitor physical 
activity in young people with Down syndrome, though energy expenditure estimates should be used 
with caution in this population. 
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People with Down syndrome typically do not participate in recommended levels of physical activity 
(Shields, Dodd et al. 2009, Temple and Stanish 2009, Esposito, MacDonald et al. 2012). A lack of 
physical activity increases the risk of people with Down syndrome developing health conditions such 
as obesity, diabetes, cancer and Alzheimer’s disease (Hermon, Alberman et al. 2001, Hill, Gridley et 
al. 2003, Zigman and Lott 2007). Risk factors for these chronic health conditions can be improved by 
participation in regular physical activity (Penedo and Dahn 2005). 
Physical activity is an important component in weight and glycaemic control, and cardiovascular and 
cognitive health. Set-duration exercise interventions, as a structured form of physical activity, 
involving aerobic and/or resistance training, appear to improve cardiovascular fitness and muscle 
strength of people with Down syndrome (Dodd and Shields 2005, Mendonca, Pereira et al. 2010, 
Shields and Taylor 2010, Shields, Taylor et al. 2013). However, less is known about the effects of 
daily physical activity levels in this population. It is important to be able to accurately assess 
unstructured daily physical activity levels of people with Down syndrome to understand the 
longitudinal effects of physical activity on health status.   
Self-reported physical activity levels are difficult to obtain in people with intellectual disability due to 
poor recall ability and non-compliance. Subjective reports are also typically inflated (Sallis and 
Saelens 2000, Pate, Freedson et al. 2002) making it important to measure physical activity 
objectively. Accelerometers are small, portable, lightweight and non-invasive devices that measure 
locomotor activity in terms of acceleration forces generated by body movement. The acceleration 
forces are combined to give the raw output termed activity counts. These counts are not 
comparable across devices due to different sensors, conversion parameters and amplification. 
Accelerometers can also give additional information on steps, estimated energy expenditure and 
gait characteristics (cadence, speed, distance travelled), which are derived from acceleration forces. 
By generating quantitative information on physical activity parameters (frequency, duration and 
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intensity), accelerometers might be useful for longitudinal studies to determine the nature of any 
associations between physical activity dose and health consequences. Accelerometers could also be 
useful to evaluate the effectiveness of interventions designed to increase physical activity.  
Few studies have objectively measured daily physical activity and energy expenditure using 
accelerometers in people with Down syndrome (Whitt-Glover, O'Neill et al. 2006, Shields, Dodd et al. 
2009, Esposito, MacDonald et al. 2012). This may be because accelerometers have not been 
validated as providing accurate measures of energy expenditure for people with Down syndrome. 
People with Down syndrome have a number of physiological characteristics, such as inherent joint 
laxity, muscle hypotonia (American Academy of Pediatrics. Committee 2001), reduced muscle 
strength (Pitetti, Climstein et al. 1992), and atypical gait patterns (Agiovlasitis, McCubbin et al. 2009, 
Smith, Stergiou et al. 2011), that may affect the relationship between their metabolic rate and 
accelerometer output during physical activity. As a result, it cannot be assumed that energy 
expenditure estimates from accelerometers will be accurate for people with Down syndrome. It has 
been previously demonstrated that the prediction of energy expenditure derived from uniaxial 
accelerometer activity counts is less accurate in people with Down syndrome than in people without 
Down syndrome (Agiovlasitis, Motl et al. 2011). This might be because uniaxial accelerometers do 
not capture mediolateral body motion which is greater in people with Down syndrome (Agiovlasitis, 
McCubbin et al. 2009). As physical activity is important for people with Down syndrome to prevent 
chronic disease, physical activity needs to be accurately and reliably measured in this population. A 
device that can provide this accuracy and reliability needs to be identified.   
The SenseWear armband and RT3 activity monitors are tri-axial accelerometers that could be used 
to assess physical activity levels and energy expenditure in people with Down syndrome. To enhance 
the interpretability of accelerometer outputs, activity count thresholds can be applied to classify 
physical activity as low, moderate or vigorous intensity for comparison with physical activity 
guidelines. Previous research in Down syndrome (Whitt-Glover, O'Neill et al. 2006, Shields, Dodd et 
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al. 2009, Esposito, MacDonald et al. 2012) has relied upon thresholds developed for healthy 
populations. Because of physiological differences and the altered relationship between energy 
expenditure and activity counts in people with Down syndrome for uniaxial accelerometers, it has 
been suggested that alternate thresholds for physical activity need to be developed in this 
population (Agiovlasitis, Motl et al. 2011). 
Neither the SenseWear armband nor the RT3 activity monitor has been validated for people with 
Down syndrome, nor have RT3 activity count thresholds been developed for people with Down 
syndrome. Therefore the primary aim of this study was to assess the reliability and validity of the 
SenseWear armband and RT3 activity monitor in estimating energy expenditure of young people 
with Down syndrome. The secondary aims were: (1) to assess the reliability and validity of 
SenseWear armband in estimating steps taken and (2) to estimate activity count thresholds for 
physical activity intensity for the RT3 monitor.   
Method 
Design 
This was a cross validation and reliability study with repeated measures. Ethics approval was 
received from the La Trobe University Human Ethics Committee (approval number 12-078). Written 
informed consent was sought from the next of kin (parent) for all adolescents (ages 14 to 17 years). 
Adolescents were also invited to provide their own written assent. For young adults with Down 
syndrome, (ages 18 years and over) competence to give consent was determined in conjunction with 
their parents. Where a young adult already in usual practice provides their own consent, they 
provided their own informed consent to participate in this study. Where a young adult was 
determined by their parents to not be cognitively able to provide their own consent, informed 
consent was sought from the next of kin and the participant was invited to provide written assent.  
Participants 
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Adolescents and young adults (aged 14 years or older) with Down syndrome and mild to moderate 
intellectual disability were invited to participate. Participants needed to be able to follow simple 
verbal instructions in English and be deemed safe, as assessed by the Physical Activity Readiness 
Questionnaire (PAR-Q) (Canadian Society for Exercise Physiology 2002) to participate in physical 
activity. The PAR-Q is a screening tool designed to determine the safety of exercising based on 
answers to specific health history questions and has been used previously in Down syndrome 
(Shields, Taylor et al. 2013). Participants were required to get medical clearance from their family 
doctor prior to participating if any answers to the PAR-Q indicated safety concerns. Participants were 
excluded if they had an acute or concurrent medical condition rendering them unfit to participate 
(such as an acute knee injury) or a significant behavioural problem that would impact on their ability 
to participate (such as noncompliance or anxiety). A convenience sample of 10 young adults was 
recruited from a previous trial (Shields, Taylor et al. 2013).  
Equipment 
The SenseWear armband activity monitora is a small device worn on the upper arm. It includes a tri-
axial accelerometer to detect motion and body position and sensors that record galvanic skin 
response, skin temperature and heat flux. The information collected by the sensors is combined with 
the participants’ sex, age, height and weight data in a proprietary algorithm to estimate energy 
expenditure reported in metabolic equivalent units (METs). METs report energy expenditure in 
multiples of the resting metabolic rate, where 1 MET is defined as the rate of oxygen uptake at rest. 
The SenseWear armband has been validated for healthy adults, young adults (Johannsen, Calabro et 
al. 2010, Wetten, Batterham et al. 2014) and children (Andreacci, Dixon et al. 2007), as well as 
clinical populations; such as people with stroke (Manns and Haennel 2012), cystic fibrosis (Dwyer, 
Alison et al. 2009) and children and adolescents with cerebral palsy (Koehler, Abel et al. 2015). 
The RT3 activity monitorb is a lightweight tri-axial accelerometer worn on a waistband at the hip. The 
RT3 provides raw data as activity counts by detecting acceleration in vertical, anteroposterior and 
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mediolateral planes. The output is in vector magnitude (VM) per minute which is calculated as the 
square root of the sum of the squared activity counts for each dimension. These data are combined 
with information on the participants’ sex, age, height and weight in a proprietary algorithm to 
estimate energy expenditure per minute expressed as calories. Estimation of energy expenditure by 
the RT3 has been validated for children (Hussey, Bennett et al. 2014) and young adults (Barreira, 
Kang et al. 2007). The RT3 has previously been used to measure physical activity in Down syndrome 
(Shields, Dodd et al. 2009, Shields, Taylor et al. 2013). Typically, VM count thresholds are applied to 
the output data to express the output as minutes spent in varying levels of physical activity to make 
it more interpretable. Count thresholds have been developed for typically developing children, 
adolescents and young men (Rowlands, Thomas et al. 2004, Vanhelst, Beghin et al. 2010) and 
children with cerebral palsy (Ryan, Walsh et al. 2014) but not for young adults with Down syndrome.    
The OxyCon Mobilec is a portable, wireless metabolic system that is secured to the participants’ 
chest with a harness and measures breath by breath gas exchange via a flow sensor unit connected 
to a face mask. The data are sent telemetrically to a base station connected to a computer and 
energy expenditure is expressed as volumetric oxygen uptake (VO2) in ml/kg/min.  Data are 
converted from VO2 to METs using the equation: 1 MET = 3.5 VO2 (ml/kg/min). Gas and volume 
calibration (reference gas tank: 16% O2; 4% CO2) were performed prior to testing using the built-in 
automated procedures. The OxyCon Mobile is a valid and reliable measure of metabolic variables 
when compared to the Douglas bag method (Rosdahl, Gullstrand et al. 2010) and the OxyCon Pro 
laboratory system (Akkermans, Sillen et al. 2012). The OxyCon Mobile has previously been used as 
the criterion measure for energy expenditure in children (Arvidsson, Slinde et al. 2007, Ryan, Walsh 
et al. 2014) and adults (Lee, Kim et al. 2014). 
Testing protocol 
Participants wore two SenseWear armbands (one on each upper arm), an RT3 monitor (on the 
waistband of their pants at their right hip) and wore the OxyCon Mobile equipment in a vest 
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connected to a facemask during testing. Due to unavailability of monitors, if only one SenseWear 
monitor was available to be worn, the left arm was chosen a priori as per manufacturer guidelines. 
To increase adherence, verbal and written information (including pictures) was provided to 
participants at least two weeks prior to the testing session. On the day of testing participants were 
familiarised with the equipment by researchers explaining how each piece of equipment worked. 
The participants were also given time before the testing commenced to become comfortable 
wearing the equipment. A researcher recorded the participant’s steps, distance walked or run, and 
rating of perceived exertion. Testing involved two 60-minute sessions, performed one week apart, 
which included the following activities: sitting, standing, walking, running and lying down (table 1). 
Duration of the walking tasks were randomised (range: 6 – 10 minutes) to provide a range of values 
for total steps taken to avoid a truncation effect in correlation. Rest periods of at least 10 minutes 
duration occurred between each walking task to allow participants to return to baseline resting 
state. Testing and re-testing were conducted by the same researchers and at the same times of day. 
The walking and running tasks were conducted indoors on a flat, 30 meter long hallway at the 
research centre.   
[INSERT TABLE 1 ABOUT HERE] 
Statistical analysis 
Data were downloaded from the SenseWear armband (Steps and METs), the RT3 monitor (VM and 
calories) and OxyCon Mobile (METs) immediately after each testing session. Data from the 
SenseWear and RT3 are expressed per minute. The last 3 useable minutes of data for each activity 
(self-selected pace walking, fast pace walking and sitting) were extracted for analysis (table 1). At 
this time data were considered to be a true reflection of the activity performed. When only one set 
of SenseWear data were needed, the left SenseWear was chosen a priori. For validity and inter-
monitor reliability, data from testing session 2 were chosen as participants were familiar with the 
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procedure. RT3 calories were converted to METs using the equation: METs = Calories per minute x 
200 / [3.5 x Weight (kg)] (Compendium of Physical Activities 2015).  
Validity – SenseWear armband and RT3 
Paired t-tests were conducted to assess differences in means and 95% confidence intervals between 
the accelerometers (SenseWear and RT3) and criterion measures (OxyCon Mobile and observer). 
Pearson’s correlation coefficients (r) were calculated to assess the strength of association between: 
1) the left SenseWear armband and the OxyCon Mobile for energy expenditure (METs); 2) the RT3 
monitor and the OxyCon Mobile for energy expenditure (METs); and 3) the left SenseWear armband 
and observation for steps. The strength of the correlation was defined according to Munro (Munro 
1993) as low (0.26-0.49), moderate (0.50-0.69), high (0.70-0.89) or very high (0.90-1.00). The 
coefficient of determination (r2) was also reported to describe the amount of variability (%) in the 
criterion measure that the SenseWear and RT3 were able to predict (Howell 1992). 
As the use of correlation alone can be misleading, methods described by Bland and Altman (Bland 
and Altman 1986) were used to assess the level of agreement in the units of measurement between 
the accelerometers (SenseWear and RT3) and the criterion measure (OxyCon Mobile) for each 
activity to improve interpretability. The difference between the two measures was plotted against 
the mean of the two measures to give the mean difference and limits of agreement between 
measurements. This allows the reader to determine whether the two methods agree sufficiently for 
one to replace the other.    
Reliability – SenseWear armband and RT3  
Intraclass correlation coefficient (ICC) and the 95% confidence interval (95%CI) and Bland-Altman 
tests to provide an estimate of reliability in the units of measurement, were used to assess reliability 
(Rankin and Stokes 1998). Re-test reliability of the SenseWear armband and the RT3 activity monitor 
between session 1 and session 2 was assessed using ICC (2,1) (Shrout and Fleiss 1979) for each 
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activity.  Inter-monitor reliability of two SenseWear armbands worn on the right and left upper arm 
of a participant in session 2 was assessed using ICC (3,1) (Shrout and Fleiss 1979).  
Thresholds for activity – RT3 only  
A Receiver Operating Characteristic (ROC) curve analysis was conducted to assess the ability of 
published thresholds, developed for typically developing children (Vanhelst, Beghin et al. 2010) and 
young men (Rowlands, Thomas et al. 2004), and children with cerebral palsy (Ryan, Walsh et al. 
2014), to detect sedentary, low-intensity and moderate to vigorous intensity physical activity and 
determine new thresholds for young adults with Down syndrome. Sensitivity, specificity, and Area 
Under Curve (AUC) values of >0.9 were considered excellent, 0.8 to 0.89 were considered good, and 
0.7 to 0.79 were considered fair. 
 
Results 
Participants 
Ten young people with Down syndrome (5 females) with a mean age of 20 (SD 2, range 16 to 24) 
years took part (table 2). Four participants were classified as having normal weight according to 
body mass index (World Health Organization 2000), 2 as overweight, and 4 as obese. Their level of 
intellectual disability was classified by their parent as mild (n=5) or moderate (n=5). Four participants 
had a heart condition that did not limit their participation. Three participants had a small patent 
ductus arteriosus requiring no intervention and one participant had mild mitral valve regurgitation 
and a permanent pacemaker in situ. All participants completed 2 testing sessions each (20 sessions).  
[INSERT TABLE 2 ABOUT HERE] 
Compliance with the trial method 
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All activities in the protocol were completed in 19 out of 20 of the testing sessions. The running task 
was not completed on one occasion due to behavioural non-compliance. OxyCon Mobile recordings 
were not retrievable for one participant due to equipment malfunction (test 1); RT3 monitor data 
were not available for one participant due to battery failure (test 1); and on six occasions the right 
SenseWear armband was not worn due to unavailability of monitors (test 1: n=4, test 2: n=2). The 
mean self-selected walking speed was 1.1 (SD 0.2) m/s and the mean fast walking speed was 1.4 (SD 
0.2) m/s. Walking speed did not differ between the two testing sessions (table 5). The running task 
was not maintained for 3 or more minutes by any participant therefore was not able to be analysed 
separately.   
Validity 
When assessing validity, data were available from the left SenseWear, RT3 and OxyCon from testing 
session 2 for all 10 participants. At rest, the SenseWear armband estimation of energy expenditure 
was not significantly different to the OxyCon Mobile and estimates were highly correlated (r=.72). 
Bland-Altman plot evaluation of limits of agreement demonstrated that energy expenditure could be 
estimated as 0.2 METs above or below the true value (figure 1a).Based on the coefficient of 
determination (r2), 52% of the variability in the OxyCon Mobile measured energy expenditure at rest 
was predicted by the SenseWear armband (table 3).  
When compared to OxyCon Mobile, the SenseWear armband significantly overestimated energy 
expenditure when participants walked at self-selected and fast pace (figure 1a). There was a 
moderate correlation between the measures at self-selected walking pace(r=.58) and a low 
correlation at fast walking pace (r=.35). This indicated between 12% and 34% of the variability in the 
OxyCon Mobile measured energy expenditure during walking was predicted by the SenseWear.  
Bland-Altman limits of agreement indicated that SenseWear could underestimate METs by 0.5 or 
overestimate METs by 3.6 for self-selected walking pace and underestimate by 1.2 METs or 
overestimate by 3.4 METs during fast walking. 
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The RT3 also significantly overestimated walking energy expenditure (figure 1b), but there was a 
high correlation with the OxyCon Mobile at self-selected walking pace (r=.82) and a moderate 
correlation at fast pace walking (r=.52) (table 3). This indicated between 27% and 67% of the 
variability in OxyCon Mobile energy expenditure could be predicted by the RT3. 
SenseWear armband step counts were very highly correlated with observed steps at self-selected 
(r=.98) and fast pace walking (r=.91), and indicated between 83% and 96% of variation in observed 
steps could be predicted by the SenseWear armband. However, the SenseWear armband 
underestimated steps during fast walking (figure 1c). 
[INSERT FIGURES 1a – 1c ABOUT HERE] 
[INSERT TABLE 3 ABOUT HERE] 
Inter-monitor reliability 
When assessing inter-monitor reliability there were complete left and right SenseWear armband 
data from 8 participants from testing session 1 used for analysis. There was good inter-monitor 
reliability of the left and right SenseWear armbands with no significant differences between energy 
expenditure estimates from the left and right armbands at rest or during walking (table 4). The 
monitors were highly correlated at rest (ICC=.86), self-selected walking pace (ICC=.97), and fast 
walking pace (ICC=.88). 
For steps, left and right SenseWear armbands were highly correlated at self-selected (ICC=.88), but 
not fast pace (ICC=-.32) walking. It was observed that during fast pace walking, participants became 
concerned with the movement of the equipment and either tried to hold the OxyCon Mobile vest 
and/or pulse oximeter still with one hand. This may have resulted in asymmetrical movement and 
different right and left armband recordings. 
[INSERT TABLE 4 ABOUT HERE] 
Re-test reliability 
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Full data from the first and second testing sessions were available for 10 participants for the 
SenseWear, 9 participants for the RT3, and 9 participants for the OxyCon Mobile. At rest, there were 
no significant differences in energy expenditure estimates between the SenseWear armbands 
between testing sessions (re-test) and high re-test reliability (ICC=.81). There was very high re-test 
correlation for the RT3 estimated energy expenditure at rest (ICC =.90) (table 5). 
For walking tasks, re-test measures of SenseWear estimated energy expenditure were highly 
correlated (self-selected ICC=.80; fast pace ICC=.72). Similar re-test results were seen for OxyCon 
Mobile data. However, re-test correlation was poor to moderate for the RT3 during walking tasks 
(self-selected ICC=.61; fast pace ICC=.46). 
For steps, there was good re-test reliability between sessions with very high correlation between the 
two testing sessions for self-selected (ICC=.96) and fast pace (ICC=.90) walking.  
[INSERT TABLE 5 ABOUT THERE] 
RT3 activity count thresholds 
For walking tasks, increases in METs recorded by the OxyCon Mobile correlated with increased RT3 
activity counts (self-selected pace r = 0.82). ROC curve analysis identified the optimal threshold of 52 
counts per minute from the RT3 to differentiate between sedentary and light physical activity with 
excellent sensitivity (1.0) and specificity (.94). The threshold for moderate intensity physical activity 
was identified as 1389 counts per minute with excellent sensitivity and specificity with an AUC of .94 
(95%CI .88 to 1). The ROC curve derived threshold for vigorous intensity physical activity was 2448 
counts per minute with excellent sensitivity and specificity with an AUC of .92 (95%CI .84 to 1). The 
resulting ranges of counts per minute are: sedentary ≤52, light >52 to ≤1389, moderate >1389 to 
≤2448 and vigorous >2448. Previously published thresholds for RT3 activity counts were acceptable 
for differentiating between sedentary and low intensity physical activity; and moderate and vigorous 
intensity physical activity; but not low and moderate intensity physical activity for young people with 
Down syndrome in this study (table 6).  
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[INSERT TABLE 6 ABOUT HERE] 
Discussion 
Results from this study indicate that the SenseWear armband and the RT3 activity monitor were 
valid and reliable measures of energy expenditure at rest for young people with Down syndrome. 
However, during walking tasks, both monitors were not valid measures as they overestimated 
energy expenditure. During walking, the SenseWear armband demonstrated good inter-monitor and 
test re-test reliability for energy expenditure while the RT3 monitor had poor to moderate test re-
test reliability. The SenseWear armband was a valid measure of steps taken and had high test re-test 
reliability but poor inter-monitor reliability during fast pace walking. We developed RT3 thresholds 
that demonstrated good to excellent sensitivity and specificity in classifying physical activity 
intensity.    
The SenseWear armband significantly overestimated energy expenditure during walking. The limits 
of agreement were large relative to what was being measured, with the SenseWear armband 
potentially overestimating energy expenditure by as much as 103% during walking at self-selected 
pace compared to the criterion measure. Overestimation of energy expenditure during walking tasks 
by the SenseWear armband has previously been demonstrated in other validation studies in healthy 
adults (Fruin and Rankin 2004, King, Torres et al. 2004) and in adults with Down syndrome 
(Mendonca 2008). It has been suggested that exercise specific algorithms need to be developed to 
increase the validity of SenseWear estimating energy expenditure (Jakicic, Marcus et al. 2004). 
Similar to the SenseWear armband, the RT3 monitor consistently overestimated energy expenditure 
during walking tasks but had a higher correlation with the criterion measure. The limits of 
agreement were still large indicating that the RT3 should also not be used to estimate energy 
expenditure in young people with Down syndrome as it could overestimate energy expenditure by 
as much as 83% during fast pace walking. Previously published activity count thresholds for 
Accelerometers in Down syndrome 
 
15 
 
differentiating between light and moderate intensity physical activity (Rowlands, Thomas et al. 2004, 
Vanhelst, Beghin et al. 2010, Ryan, Walsh et al. 2014) appeared to be too low as they incorrectly 
identified low intensity physical activity as moderate in participants of the current study. This would 
result in an over-estimation of the physical activity levels of young people (aged 16 to 24 years) with 
Down syndrome in our study. Use of thresholds developed in this paper may be a more accurate 
way of classifying physical activity intensity based on the RT3 activity monitor data for this 
population.  
The SenseWear armband was a valid measure of steps at self-selected and fast pace walking and had 
very high re-test reliability at both speeds. There was high inter-monitor correlation between the left 
and right SenseWear armbands at self-selected walking pace, but not at fast walking pace. The low 
correlation at fast pace walking may be attributable to participants changing their movement 
patterns due to OxyCon Mobile equipment movement at faster walking speeds. This may have 
clinical implications for physical activity monitoring with an armband if a person is carrying an object 
while walking. It also demonstrates some issues with the OxyCon Mobile equipment at fast pace 
walking in this population, as they were unable to ignore the equipment movement. Even though 
correlations were high, Bland-Altman limits of agreement show that the SenseWear armband could 
underestimate steps by as much as 18% during fast pace walking.   
Accelerometers are designed to measure acceleration. The indirect estimation of energy 
expenditure from accelerometer data uses proprietary algorithms and a number of assumptions to 
convert raw accelerometer activity counts to energy expenditure. These assumptions may 
contribute to error in the estimation of energy expenditure for people with Down syndrome. Raw 
activity counts (which are directly derived from accelerations) and steps (which are more closely 
related to acceleration) appear to be more accurate than energy expenditure estimates and 
therefore appropriate to use in this population.    
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The overestimation of energy expenditure during walking in young adults with Down syndrome by 
both tri-axial accelerometers may also partially be explained by the inefficient movement patterns of 
people with Down syndrome. People with Down syndrome have inherent joint laxity, muscle 
hypotonia (American Academy of Pediatrics 2001), reduced muscle strength (Pitetti, Climstein et al. 
1992), and atypical gait patterns (Smith, Stergiou et al. 2011) which appear to result in greater 
movement variations during gait (Agiovlasitis, McCubbin et al. 2009). Exaggerated movements may 
result in larger body accelerations and subsequently higher SenseWear and RT3 activity counts. 
When compared to adults without Down syndrome, instrumented gait analysis shows that adults 
with Down syndrome have greater mediolateral movement during gait (Agiovlasitis, McCubbin et al. 
2009). At most walking speeds however, the vertical and anteroposterior movements are not 
different between people with and without Down syndrome, but were more variable for people with 
Down syndrome (Agiovlasitis, McCubbin et al. 2009). This might help to explain the differences 
between this current study and the study by Agiovlasitis (Agiovlasitis, Motl et al. 2011) that used a 
uniaxial accelerometer that only measures acceleration in the vertical direction. That study found 
that published activity count thresholds for the Actigraph were too high for people with Down 
syndrome whereas in the current study, published RT3 thresholds appeared to be too low. The 
uniaxial accelerometer used in that study would not detect mediolateral movement and therefore 
may underestimate activity. The tri-axial accelerometers used in this current research would pick up 
the increased mediolateral movement. Because algorithms that convert activity counts to estimated 
energy expenditure were developed in healthy populations, the increased mediolateral activity 
counts may be overly weighted in the algorithm which may cause an overestimation of energy 
expenditure by the tri-axial accelerometers above the true increase in energy expenditure measured 
by the OxyCon Mobile.  
Energy expenditure during rest and walking has been previously measured for people with Down 
syndrome with conflicting results. Some research suggests that people with Down syndrome may 
have a lower resting metabolic rate than people without Down syndrome (Luke, Roizen et al. 1994, 
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Allison, Gomez et al. 1995). Other studies found higher walking energy expenditure in people with 
Down syndrome (Agiovlasitis, McCubbin et al. 2009) and people with intellectual disability (including 
Down syndrome) (Lante, Reece et al. 2010). However, no differences were found in resting energy 
expenditure (Fernhall, Figueroa et al. 2005) or during walking (Mendonca, Pereira et al. 2009) 
between people with and without Down syndrome in other studies. Conflicting results in previous 
research may be due to different participant characteristics such as age. Based on this past research, 
we cannot assume people with Down syndrome are a homogeneous group in terms of energy 
expenditure, therefore our results are specific for young people (aged 16 to 24 years) with Down 
syndrome.   
There are a number of limitations that need to be addressed. We only assessed overground walking 
at two submaximal intensities which meant that there were few light and vigorous activities 
recorded. The uneven number of bouts in each activity category (sedentary, light, moderate and 
vigorous) may have impacted the specificity and sensitivity of our results. Face mask fit and air 
leakage may be a problem for people with Down syndrome due to small nose and flatter facial 
features; however, a small sized face mask was chosen and checked for air leaks prior to testing. 
Lastly, the sample size was relatively small.  Despite this, the sample size was sufficient to detect 
significant differences and correlations. In addition, our results cannot be extended to children 
younger than 16 years of age or adults older than 24 years.     
Future directions 
Future research should expand the evidence-base of the psychometric properties of activity 
monitors such as SenseWear and RT3 in larger samples and across a broader range of physical 
activities. In addition, the causes of discrepancies in energy expenditure estimation could be 
explored, particularly in relation to movement patterns of people with Down syndrome. The RT3 
activity count thresholds for physical activity intensity for people with Down syndrome presented in 
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this study are preliminary and it is recommended that their accuracy be assessed in a larger 
population of youth with Down syndrome and in other age groups.   
Conclusion 
Both the SenseWear armband and RT3 tri-axial accelerometers overestimated energy expenditure 
during walking tasks in young people with Down syndrome. This implies that energy expenditure 
estimates from both monitors should not be used for people with Down syndrome in research on 
achieving physical activity guidelines and longitudinal health studies evaluating physical activity 
levels as both would overestimate time spent in moderate to vigorous physical activity. SenseWear 
and RT3 monitors may have applications in estimating indicators of daily physical activity, by 
measuring steps, and in the case of the RT3, by accurately assessing counts so that time spent 
performing moderate and vigorous intensity physical activity can be estimated in young people with 
Down syndrome. 
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Figure legend 
Figure 1a. Bland-Altman plot for agreement between SenseWear and OxyCon (METs) with a line at 0 – no 
difference. Note: Δ = rest, ○ = self-selected walking pace, □ = fast walking pace.         
Figure 1b. Bland-Altman plot for agreement between RT3 and OxyCon (METs) with a line at 0 – no 
difference. Note: Δ = rest, ○ = self-selected walking pace, □ = fast walking pace. 
Figure 1c. Bland-Altman plot for agreement between SenseWear and observer (steps) with a line at 0 – 
no difference. Note: ○ = self-selected walking pace, □ = fast walking pace. 
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Table 1. Testing protocol (in order of performance) 
Activity Duration (minutes) 
Sitting 3 
Standing 2  
Sitting 3 
Walk 1: comfortable pace, familiarisation 6 
Sitting 3 
Lying down 10 
Standing 2 
Sitting 3 
Walk 2: self-selected pace* 6 – 10 
Sitting* 10 
Walk 3: fast pace* 6 – 10 
Running ≥ 1 
NB: * data extracted for analysis from these activities 
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Table 2. Participant characteristics 
Characteristic  
Age, mean (SD) 
        Adolescent (10 to <18 years)  
        Young adult  
20 (2) 
2 
8 
Height (cm), mean (SD) 157.2 (8.9) 
Weight (kg), mean (SD) 67.7 (13.1) 
Gender (Male: Female) 5:5 
Body Mass Index, mean (SD) 
        Normal range (18.5 to 24.9) 
        Overweight (25 to 29.9) 
        Obese (≥30) 
27.4 (4.9) 
4 
2 
4 
Type of Down Syndrome 
Trisomy 21 
 
10 
Level of intellectual disability 
Mild 
Moderate 
 
5 
5 
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Table 3. Validity of SenseWear and RT3 (n=10, data from test 2) 
Activity Mean (SD) Mean difference (95%CI) Correlation Bland-Altman 
SenseWear energy expenditure (n=10) 
 SenseWear METs OxyCon METs SenseWear - OxyCon p Pearson’s r r2 Limits of agreement 
Rest 1.1 (0.1) 1.1 (0.1) -0.03 (-0.09 to 0.04) 0.35 0.72 .52 -0.2 to 0.2 METs 
Walking pace         
   Self-selected  5.0 (0.6) 3.5 (1.2) 1.5 (0.8 to 2.3) 0.001 0.58 .34 -0.5 to 3.6 METs 
   Fast 5.7 (0.6) 4.6 (1.2) 1.1 (0.8 to 1.9) 0.015 0.35 .12 -1.2 to 3.4 METs 
RT3 energy expenditure (n=10) 
 RT3 METs* OxyCon METs RT3 - OxyCon p Pearson’s r r2 Limits of agreement 
Rest 1.1 (.1) 1.1 (0.1) -0.1 (-.12 to .01) .07 .72 .52 -0.2 to 0.1 METs 
Walking pace        
   Self-selected 4.7 (.9) 3.5 (1.2) 1.2 (.7 to 1.8) <.001 .82 .67 -.2 to 2.7 METs 
   Fast 6.2 (0.9) 4.6 (1.2) 1.6 (.8 to 2.4) <.001 .52 .27 -0.5 to 3.8 METs 
SenseWear steps (n=10) 
 SenseWear Steps Observed Steps SenseWear - Observed p Pearson’s r r2 Limits of agreement 
Walking pace        
   Self-selected  884 (214) 903 (220) -18 (-51 to 15) 0.24 0.98 .96 -110 to 74 steps 
   Fast 1096 (116) 1165 (159) -69 (-120 to -18) 0.014 0.91 .83 -212 to 74 steps 
NB: SD=standard deviation; CI=confidence interval; MET=metabolic equivalent; *RT3 calories were converted to METs using the equation METs = Calories 
per minute x 200 / [3.5 x Weight (kg)] (AHA 1995). 
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Table 4. Inter-monitor reliability of the SenseWear monitor using Intraclass Correlation Coefficients (2,1) (ICC) and 95% confidence intervals (CIs) (n=8 
complete sets of data) 
NB: MET=metabolic equivalent; SD=standard deviation; ICC=intraclass correlation coefficient. CI=confidence interval 
 
 
 
  
 
Activity 
Energy Expenditure (METs),        
Mean (SD) 
Correlation between left 
and right SenseWear METs 
Steps, Mean (SD) Correlation between left 
and right SenseWear steps 
Left 
SenseWear 
Right 
SenseWear 
ICC (95% CI) Left 
SenseWear 
Right 
SenseWear 
ICC (95%CI) 
Rest 1.1 (.1) 1.1 (.1) .86 (.32 to .97)    
Walking at own pace 5.2 (1) 5.4 (1) .97 (.88 to 1) 830 (138) 774 (182) .88 (.39 to .98) 
Walking at fast pace 5.7 (.7) 5.8 (.9) .88 (.4 to .98) 1058 (128) 994 (267) -.32 (-5.58 to .74) 
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Table 5. Re-test reliability of the SenseWear and RT3 monitors using Intraclass Correlation 
Coefficients (2,1) (ICC) and 95% confidence intervals (CIs)  
Activity Mean (SD) Correlation between day 
1 and day 2 
SenseWear energy expenditure (n=10) 
 Day 1 METs Day 2 METs ICC (95%CI) 
Rest 1.1 (0.1) 1.1 (0.1) .81 (.22 to .95) 
Self-selected pace walking 5.2 (1.0) 5.0 (0.6) .80 (.19 to .95) 
Fast pace walking 5.7 (0.7) 5.7 (0.6) .72 (-.11 to .93) 
RT3 energy expenditure (n=9) 
 Day 1 METs Day 2 METs ICC (95%CI) 
Rest 1.1 (.1) 1.1 (.1) 0.9 (.56 to .98) 
Self-selected pace walking 4.5 (.9) 4.6 (.7) .61 (-.75 to .91) 
Fast pace walking 5.8 (.7) 6 (.7) .46 (-1.4 to .88) 
Criterion measure: OxyCon Mobile (n=9) 
 Day 1 METs Day 2 METs ICC (95%CI) 
Rest 1.1 (0.1) 1.1 (0.1) .58 (-.88 to .90) 
Self-selected pace walking 3.4 (1.0) 3.5 (1.2) .97 (.87 to .99) 
Fast pace walking 4.3 (1.2) 4.6 (1.2) .9 (.56 to .98) 
SenseWear steps (n=10) 
 Day 1 steps Day 2 steps ICC (95%CI) 
Self-selected pace walking 869 (220) 884 (214) .96 (.83 to .99) 
Fast pace walking 1074 (121) 1096 (116) .90 (.59 to .98) 
Criterion measure: observed steps (n=10) 
 Day 1 steps Day 2 steps ICC (95%CI) 
Self-selected pace walking 916 (229) 903 (220) .99 (.95 to 1) 
Fast pace walking 1166 (169) 1165 (159) .91 (.65 to .98) 
 Observed speed, m/s (n=10)  
 Day 1 speed Day 2 speed ICC (95%CI) 
Self-selected pace walking 1.1 (0.2) 1.1 (0.2) .87 (.46 to .97) 
Fast pace walking 1.4 (0.2) 1.4 (0.2) .92 (.69 to .98) 
NB: SD=standard deviation; ICC=intraclass correlation coefficient; CI=confidence interval; 
MET=metabolic equivalent, m/s=speed in meters per second  
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Table 6. Sensitivity and specificity of previously published cut points and the current studies newly developed cut points for physical activity level. 
 
 
 
 
 
 
 
 
 
NB: TD=typically developing, CP=cerebral palsy, DS=Down syndrome  
 Author Population Cut point (counts/minute) Sensitivity (%) Specificity (%) 
Light physical activity  
(>2 to <3 METs) 
Vanhelst (2010) TD children 10-16years, n=40 >41 100 89 
Ryan (2014) Children with CP, n=18 >51.9 100 94 
Current paper Young adults with DS, n=10 
 
>52 100 94 
Moderate physical 
activity  
(3 to 6 METs) 
Vanhelst (2010) TD children 10-16years, n=40 >950 100 60 
Ryan (2014) Children with CP, n=18 >689.3 100 56 
Rowlands (2004) TD young men, n=19 >984 100 56 
Current paper Young adults with DS, n=10 
 
>1389 100 81 
Vigorous physical 
activity (>6METs) 
Vanhelst (2010) TD children 10-16years, n=40 >3410 0 100 
Rowlands (2004) TD young men, n=19 >2341 100 83 
Current paper Young adults with DS, n=10 >2448 100 88 
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